Pharma and Biotech
By Sean Farrell
Date: Thursday 15 Jul 2021
(Sharecast News) - Nuformix's annual loss widened as revenue fell and the pharmaceutical company spent to development its treatments.
By Sean Farrell
Date: Wednesday 10 Feb 2021
(Sharecast News) - Chris Blackwell has quit as Nuformix's chairman a year after taking the job at the drug development company.
By Josh White
Date: Thursday 18 Jul 2019
(Sharecast News) - Nuformix reported total revenue of £0.61m in its final results on Thursday, rising from £0.02m in the prior year, with the company swinging to a gross profit of £0.07m, from a loss of £0.19m.
Currency | UK Pounds |
Share Price | 0.26p |
Change Today | 0.030p |
% Change | 13.04 % |
52 Week High | 0.30p |
52 Week Low | 0.048p |
Volume | 60,850,575 |
Shares Issued | 1,995.71m |
Market Cap | £5.19m |
RiskGrade | 322 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:36 | 3,823,386 @ 0.27p |
16:27 | 181,880 @ 0.27p |
16:25 | 500,000 @ 0.27p |
16:20 | 200,000 @ 0.26p |
16:14 | 370 @ 0.27p |
You are here: research